Asahi Kasei Pharma will offer selected candidates collaborative research opportunities, with research funding and contribution to the program through our scientists’ research activities. We believe that such efforts to advance drug... read more →
Requests for proposals
Check our tech requests from industry
BOLD Awards is aiming to engage more than 3,000 global nominees from the public and private sector, with only the top 60 being selected to join us in Venice, Italy,... read more →
Japanese manufacturer specialized in the production of ultrasonic transducer, “Japan Probe Co.,LTD” is currently seeking partners (specifically researchers in ultrasound area) to develop imaging solutions and further innovative products in the... read more →
The application deadline is 11: 59 AM, October 2, 2019 (JST) ILS Challenge with Tokyu Accelerate Program ILS Challenge with Tokyu Accelerate Program selected companies (scheduled to be selected 5... read more →
The deadline for application is Sep 20th, 2019 AM 11: 59 (JST) ILS Challenge with Nikon ILS Challenge with Nikon selected companies (scheduled to be selected 5 companies) will present... read more →
OVERVIEW Objective We are seeking proposals for innovative big businesses that lead to a new global platform to solve SDGs (17 global challenges) by synthesizing service solutions provided by NTT... read more →
Japanese specialty pharmaceutical company, “EA Pharma Co., Ltd.” is currently seeking drug/target candidates for Pancreatic diseases. EA Pharma Co., Ltd. is a gastrointestinal specialty pharma, established in April 2016 through... read more →
Join TaNeDS Global 2019 Learn more about Daiichi Sankyo's open competition grant program. What is TaNeDS? TaNeDS (Take a New Challenge for Drug diScovery) program provides close partnership between you... read more →
Cristal Therapeutics is a clinical stage biopharmaceutical company developing tissue- targeted nanomedicines based on its proprietary CriPec® polymeric nanoparticle technology platform for the treatment of cancer and other diseases with... read more →
A midsize Japanese pharmaceutical company having an R&D with a consistent manufacturing capability is seeking drug discovery project for accelerating hit generation of small molecules. This company is part of... read more →